These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29364462)

  • 1. Dapsone-induced agranulocytosis in patients with Hansen's disease.
    Fernandes TRMO; Jesus BN; Barreto TT; Pereira AA
    An Bras Dermatol; 2017; 92(6):894-897. PubMed ID: 29364462
    [No Abstract]   [Full Text] [Related]  

  • 2. Total agranulocytosis caused by dapsone therapy for tuberculoid leprosy--an unappreciated serious side effect of anti-leprosy treatment with clinical implications.
    Satarasinghe RL; Jayawardana MA; De Silva GV; Murugathas S; Riyaaz AA; Wickrmasingha UD; Wijesinghe R
    Drug Metabol Drug Interact; 2009; 24(2-4):325-9. PubMed ID: 20408505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone agranulocytosis in a leprosy patient.
    Hiran S; Pande TK; Pani S; Vishwanathan KA
    Lepr Rev; 1994 Sep; 65(3):279-81. PubMed ID: 8942159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone syndrome: an incomplete form.
    Jaswal R; Thami GP; Kanwar AJ
    Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
    [No Abstract]   [Full Text] [Related]  

  • 6. Sparing of tuberculoid leprosy patch in a patient with dapsone hypersensitivity syndrome.
    Ng PP; Goh CL
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):646-8. PubMed ID: 9777777
    [No Abstract]   [Full Text] [Related]  

  • 7. Dapsone-induced agranulocytosis in a patient of leprosy.
    Mishra M; Chhetia R
    Indian J Dermatol Venereol Leprol; 2006; 72(6):456-7. PubMed ID: 17179627
    [No Abstract]   [Full Text] [Related]  

  • 8. Dapsone-induced haemolytic anaemia, hepatitis and agranulocytosis in a leprosy patient with normal glucose-6-phosphate-dehydrogenase activity.
    Ranawaka RR; Mendis S; Weerakoon HS
    Lepr Rev; 2008 Dec; 79(4):436-40. PubMed ID: 19274991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ominous sign of a disfiguring disease. Leprosy (Hansen's disease).
    Winter CA; Hsu S
    Postgrad Med; 2000 May; 107(5):87-9. PubMed ID: 10844944
    [No Abstract]   [Full Text] [Related]  

  • 11. Dapsone induced acute photosensitivity dermatitis; a case report and review of literature.
    De D; Dogra S; Kaur I
    Lepr Rev; 2007 Dec; 78(4):401-4. PubMed ID: 18309716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hansen's disease in a patient with a history of sarcoidosis.
    Burdick AE; Hendi A; Elgart GW; Barquin L; Scollard DM
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):307-11. PubMed ID: 11221094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
    Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
    Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperpigmented Macule on the Palm and Diminished Sensation.
    Awali R; Chandrasekar PH
    JAMA; 2018 Nov; 320(19):2029-2030. PubMed ID: 30304352
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 17. Autochthonous borderline tuberculoid leprosy in a man from Florida.
    Villada G; Zarei M; Romagosa R; Forgione P; Fabbrocini G; Romanelli P
    Lepr Rev; 2016 Mar; 87(1):101-3. PubMed ID: 27255063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 19. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spared white islands in a drug rash: revisiting sparing phenomenon in Hansen's disease.
    Gopinath H; Nayak K; Kumar P; Chakraborti S
    Int J Dermatol; 2017 May; 56(5):e102-e104. PubMed ID: 28194775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.